The Next Phase of Cell & Gene Therapy: Understanding the Evolving Regulatory Landscape
Cell and Gene Therapy Regulatory Landscape has evolved significantly over the past decade—from an emerging field requiring extensive regulatory caution to a maturing therapeutic modality supported by growing clinical, manufacturing, and regulatory experience. As cell and gene therapy (CGT) continues to advance, the regulatory approach is also evolving. Regulators and developers now have access to […]